Edition:
United States

Strongbridge Biopharma plc (SBBP.OQ)

SBBP.OQ on NASDAQ Stock Exchange Global Select Market

6.35USD
3:59pm EST
Change (% chg)

$0.25 (+4.10%)
Prev Close
$6.10
Open
$6.05
Day's High
$6.38
Day's Low
$6.00
Volume
17,971
Avg. Vol
40,408
52-wk High
$8.20
52-wk Low
$2.05

Chart for

About

Strongbridge Biopharma plc is a global commercial-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies for a range of diseases. The Company's commercial product, KEVEYIS (dichlorphenamide), is indicated for the treatment of hyperkalemic, hypokalemic and related variants of... (more)

Overall

Beta: --
Market Cap(Mil.): $242.86
Shares Outstanding(Mil.): 39.81
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.96 15.25
EPS (TTM): -- -- --
ROI: -- 15.07 33.27
ROE: -- 16.58 16.35

BRIEF-Strongbridge Biopharma Q3 loss per share $0.98

* Strongbridge Biopharma Plc provides corporate update and reports third quarter 2017 financial results

Nov 14 2017

BRIEF-Strongbridge Biopharma Plc announces proposed public offering of ordinary shares

* Strongbridge Biopharma Plc announces proposed public offering of ordinary shares

Oct 03 2017

BRIEF-Armistice Capital Llc reports 5.1 percent passive stake in Strongbridge Biopharma

* Armistice Capital Llc reports 5.1 percent passive stake in Strongbridge Biopharma Plc as of Sept 12, 2017 - SEC filing Source text: (http://bit.ly/2xlELBz) Further company coverage:

Sep 22 2017

BRIEF-Strongbridge Biopharma secures $53 mln financing from CRG

* Strongbridge Biopharma Plc secures $53 million financing from crg

Jul 17 2017

Earnings vs. Estimates